Latest news

Future of the ‘safety features’ measures under FMD in Great Britain and Northern Ireland (16th November 2020)

Now that the UK has left the EU and the Transition Period ends on 31st December 2020, some regulatory requirements will no longer apply. However, certain EU legislation will continue to have effect in Northern Ireland under the Northern Ireland Protocol.

An update from UK FMD Working Group for Community Pharmacy explains how this will impact on the application of the Falsified Medicines Directive. Read more…

FMD and Brexit (21st February 2020)

The serialisation and authentication requirements of the EU Falsified Medicines Directive (FMD) came into force on 9 February 2019. The UK is still subject to EU regulations during the post-Brexit transition period which will run until at least 31st December 2020.

The General Pharmaceutical Council has stated it will take action if pharmacies “blatantly disregard FMD”. Read more…

Wording of UK FMD hub alert messages being updated (8th March 2019)

SecurMed, the organisation which runs the UK Falsified Medicines Directive (FMD) hub, will be changing the wording of the eleven alert messages and one related system message produced by the hub when the data on the pack of a medicine gives cause for concern for its authenticity. Read more…

Interim guidance on FMD alerts published (7th February 2019)

The final phase of FMD implementation begins on 9th February 2019. FMD is a huge project and it is important that during the initial period, medicines are not unreasonably withheld from patients, unless there is a high degree of suspicion that the pack might be falsified. Read more…

Statement from UK FMD Working Group for Community Pharmacy (29th January 2019)

Community pharmacies must work towards compliance with the Falsified Medicines Directive (FMD) in time for February 9th deadline irrespective of any Brexit scenario, pharmacy bodies have said. Read more…

Read all news items in the News archive